Please use this identifier to cite or link to this item:
Title: Budget impact analysis of oral Fisiogen Ferro Forte versus intravenous iron for the management of iron deficiency in chronic kidney disease in Spain
Author: Darbà, Josep
Ascanio, Meritxell
Keywords: Dèficit de ferro
Insuficiència renal crònica
Anàlisi econòmica
Cost de l'assistència sanitària
Iron deficiency diseases
Chronic renal failure
Economic analysis
Cost of medical care
Issue Date: Sep-2018
Publisher: Springer Nature
Abstract: Iron deficiency is a frequent complication of chronic kidney disease (CKD) that is associated with a decrease in the quality of life of patients and an increase in the risk of other clinical complications. Iron therapy represents one of the fundamentals of patients with CKD. Sucrosomial® oral iron allows Fisiogen Ferro Forte® to be used in all patients who are intolerant to treatment by the oral route of administration, or who present with malabsorption of conventional oral iron preparations.
Note: Versió postprint del document publicat a:
It is part of: Clinical Drug Investigation, 2018, vol. 38, num. 9, p. 801-811
Related resource:
ISSN: 1173-2563
Appears in Collections:Articles publicats en revistes (Economia)

Files in This Item:
File Description SizeFormat 
686009.pdf751.38 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.